52 results about "Positive airway pressure device" patented technology

Headwear is adapted for use by a patient to position airway tubes of a nasal interface operatively connected to a positive airway pressure device. The headwear includes an elongated head strap for being worn around a head of the patient. First and second tube holders are attached to the head strap, and adapted for engaging and holding respective airway tubes of the nasal interface to retain the tubes in a desired position during use. Each of the tube holders includes an elastic strip extending along a longitudinal dimension of the head strap. The elastic strip cooperates with the head strap to form an eye for receiving an airway tube of the nasal interface.

Airway monitoring apparatus 30 includes a driver 6 for applying sound in the audible frequency range to the airway of a subject and a detector 7 for monitoring the response of the airway, e.g. by detecting transmitted sound signal components and/or reflected sound signal components. Variations in the detected sound signal, e.g. energy, due to attenuation of the signal, give an indication of the state of the airway, e.g. airway patency, and can be used to monitor sleep-disordered breathing events, such as apnea and hypopnea, and to provide a breathing event index, e.g. AHI. The apparatus may provide servo-control for a respiratory assist device, such as a positive airway pressure device, so as to provide an appropriate pressure level setting. It may allow for home use of such devices and for home titration. It may also assist in discriminating central and obstructive breathing events, and in providing a measure of airway resistance.

Systems and methods provide for detecting snoring, and for determining the presence of sleep disordered breathing using detected snoring. Snoring indicative signals generated by one or more patient-internal or external sensors are detected. The presence of sleep disordered breathing is algorithmically determined, patient-internally or externally, using the snoring signals. Algorithmically determining presence of sleep disordered breathing may include computing a snoring index developed from the detected snoring. Sleep apnea may be detected using the snoring index. Sleep apnea may be verified using internal or external sensors. A positive airway pressure device may operate cooperatively to verify and treat sleep disordered breathing.

A Discontinuous Positive Airway Pressure (DPAP) device and method of using the same for reducing sleep disordered breathing events, such as sleep apnea and snoring. The DPAP device provides selective excitation to the pharyngeal conduit or another muscle or cartilage along the respiratory path, a predetermined period of time before the end of the expiration stage, in order to prematurely reverse the respiratory cycle before the total collapse of the pharyngeal conduit, thus enabling the inhalation stage to reopen and refill the pharyngeal conduit.

A portable cradle for carrying a PAP device includes a base and a handle that is provided on the base. The base is structured to receive the PAP device and attachments to the PAP device. The base is oriented in a substantially horizontal position when the handle is lifted. A trolley may be provided to easily wheel the PAP device and store multiple accessories. Detachable battery packs may also be provided for attachment to a cradle.

A portable continuous positive airway pressure (CPAP) device is adapted for delivering gas under pressure to a patient. The CPAP device comprises a portable housing assembly, a motor blower unit disposable within the portable housing assembly, a user interface configured to be engaged to the patient, and a patient hose extending between the user interface and the motor blower unit. The portable housing assembly may be comprised or configured as a wearable frontpack assembly which is configured to be worn against the patient's chest. The frontpack assembly may include a pair of shoulder straps configured to extend over the patient's shoulders and under the patient's arms to secure the CPAP device to the patient. The motor blower unit may be remotely disposed from the portable housing assembly such as on a bedside assembly or on a tabletop stand.

A portable, efficient, integrated humidification system for use, e.g., with a positive airway pressure devices. The portable, efficient, integrated humidification system described herein offers many advantages over current humidification systems! There are many advantages to a portable respiratory humidifier. Portability reduces the amount of space the humidifier occupies in the user's bedroom environment. Portability enhances travel for the user. With less to pack, carry, and manage, the user is more likely to remain adherent to therapy when not at home. Portability allows for better utilization in recreational vehicles, while camping, in foreign countries, in the sleeping cabins of trucks or airliners, and on marine craft.

CPAP treatment apparatus is disclosed having a controllable positive airway pressure device. A sensor generates a signal representative of patient respiratory flow that is provided to a controller. The controller is operable to determine the occurrence of an apnea from a reduction in respiratory airflow below a threshold determined from long term ventilation. When an apnea or hypopnea has occurred the calculation of the threshold is suspended until the end of that event.

The present invention is related a nasal positive airway pressure device. The nasal device utilises an engagement means located about nasal cannulae to engage and secure the cannulae within the nares of a patient. The engagement means is a nasal scaling flap. The flap in its natural bias is tapered, the wide-open end of which is shaped to conform to the facial contours of a patient's nose around the outside of the nose. Thus in a closed form, the flap provides a cup-like device that is fitted around the patient's nose and prevent the nasal device from falling from the patients nose. In the open form, which allows for placement and fitting of the nasal device, the flap is intended to be in a bent back position to aid insertion of the nasal cannulae into the patient's nares.

A CPAP system includes a PAP device (5) structured to generate a supply of pressurized air, a patient interface (15) adapted to engage with the patient's face to provide a seal, an air delivery conduit (102,104) provided between the PAP device and the patient interface to deliver the supply of pressurized air along a gas delivery path from the PAP device to the patient interface, and a muffler (100) provided along the gas delivery path downstream of the PAP device.

An apparatus configured to provide positive airway pressure in a respiratory circuit comprises a container configured to be filled to a preselected level with liquids; a drop tube assembly comprising a hollow gas tube rotatably mounted in said container having an upper end extending a static distance outwardly of the container and connected to a respiratory circuit downstream of a user, and a hollow drop tube reciprocally movable upwardly and downwardly in the liquid in response to rotational movement of the gas tube. The container is provided with a gas vent and a liquid fill port.

A gas therapy system involves sensing the blood gas concentration of the patient and adapting a gas therapy based on the sensed gas concentration. Disordered breathing may be detected bases on blood gas concentration, and gas or cardiac electrical therapy may be adapted to treat the detected disordered breathing. One or more of sensing the blood gas concentration, detecting disordered breathing, or adapting the therapy may be performed at least in part implantably. The gas therapy is delivered to the patient through an external respiratory device, such as a positive airway pressure device.

The present invention pertains to a device (1) for the treatment of, treatment of complications arising from, and/or preventing respiratory disorders caused by bacterial, viral, protozoal, fungal and/or microbial infections, preferably for the treatment of complications arising from cystic fibrosis (CF), including a positive airway pressure device (2) for providing a breathing gas under a positive pressure to a patient interface (20), a source of nitric oxide (3) for providing gaseous nitric oxide, a gas injector (4) for injecting nitric oxide provided by the source of nitric oxide (3) into the breathing gas provided by the positive airway pressure device (2) under pressure, a flow rate sensor (5) for sensing the flow rate of the breathing gas provided to the patient interface (20) under positive airway pressure, and a controller (6) programmed for controlling the gas injector (4) for injecting the nitric oxide into the breathing gas provided by the positive airway pressure device (2) when a flow rate detected by the flow rate sensor (5) exceeds a predetermined threshold flow rate.